Curriculum vitae Gert Höffken - Deutsche Gesellschaft für ...

Publikationen seit 1999
Höffken, G., Pasold, R., Pflüger, K.H., Finke, J., Fauser, A.A., Szelenyi, H., Wagner, J. and the
German Multicentre Study Group. An open, randomized , multicentre study comparing the use of
low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic
patients. Journal of Antimicrobial Chemotherapy. 1999; 44: 367-376
Publication on Phase IV study
Höffken, G., Bäthge, G., Kiderlen, A.F..
Pathogenese der Pneumocystis carinii Pneumonie.
Pneumologie 1999; 53: 530-538
Höffken, G.
Epidemiology of respiratory tract infection.
European Respiratory Review 2000; 10: 149-155
Höffken, G.
Is the use of narrow-spectrum antibiotics too narrow-minded in the treatment of severe infections?
Clinical Microbiology and Infection 2000; 6 (Suppl. 2): 7-10
Landen, H, Möller, M, Tillotson, GS, Kubin, R, Höffken, G.
Clinical experience in Germany of treating community-acquired respiratory infections with the new
8-Methoxyfluoroquinolone, Moxifloxacin.
The Journal of International Medical Research 2001; 29: 51-60
Rubens, C., Ewert, R., Halank, M., Wensel, R., Orzechowski, H.-D., Schultheiss H.-P., Höffken, G.
Big-Endothelin-1 and Endothelin-1 Plasma Levels are Correlated With the Severity of Primary
Pulmonary Hypertension.
Chest 2001; 120: 1562-1569
Höffken, G., Meyer, HP, Winter, J, Verhoef, L., CAP1 Study Group.
The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the
treatment of community-acquired pneumonia.
Respiratory Medicine 2001; 95: 553-564
Publication on Phase III study
Jung, C., Buhl, M., Eichler, I., Borner, K., Höffken, G., Offermann, G.
Orales versus intravenöses Ganciclovir in der präemptiven Therapie der Zytomegalievirusinfektion
nach Nierentransplantation.
Transplantationsmedizin 2001; 13: 37-43
Gillissen, A., Höffken, G.
Early therapy with neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
Med. Microbiol. Immunol. 2002; 191: 165-168
Höffken, G., Vogel, F., Huber, C.
Wirksamkeit von Ceftazidim bei schweren nosokomialen Infektionen
Chemotherapie-Journal 2002; 11: 207-213
Finch, R., Schürmann, D., Collins, O., Kubin, R., McGivern, J., Bobbaers, H., Izquierdo, J.L.,
Nikolaides, P., Ogundare, F., Raz, R., Zuck, P., Höffken, G.
A randomised controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with
sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with communityacquired
pneumonia requiring initial parenteral treatment.
Antimicrobial Agents and Chemotherapy 2002; 46: 1746-1754
Publication on Phase III study
Höffken, G., Gillissen, A.